1-12 of 12
Arliene Ravelo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Comparison of Healthcare Costs of Venetoclax-Obinutuzumab Vs. Btki Use Among Elderly U.S. Medicare Beneficiaries with Chronic Lymphocytic Leukemia in the Front-Line (1L) Setting

Beenish S Manzoor, Scott F. Huntington, Dureshahwar Jawaid, Justin T. Puckett, Nnadozie Emechebe, Arliene Ravelo, Sachin Kamal-Bahl, Jalpa A. Doshi
Journal: Blood
Blood (2023) 142 (Supplement 1): 5085.
https://doi.org/10.1182/blood-2023-177939
Published: 2023
Journal Articles

Patient Preferences for Fixed Versus Treat-to-Progression Therapies in Chronic Lymphocytic Leukemia

Arliene Ravelo, Kelley Myers, Claire Ervin, Robyn Brumble, Cooper Bussberg, Brian Koffman, Beenish S Manzoor, Juliana M. L. Biondo, Carol Mansfield
Journal: Blood
Blood (2023) 142 (Supplement 1): 3706.
https://doi.org/10.1182/blood-2023-174719
Published: 2023
Journal Articles

Understanding Patient Preferences for Chronic Lymphocytic Leukemia Treatments

Arliene Ravelo, Kelley Myers, Robyn Brumble, Cooper Bussberg, Brian Koffman, Beenish S. Manzoor, Juliana Biondo, Carol Mansfield
Journal: Blood
Blood (2022) 140 (Supplement 1): 10803–10805.
https://doi.org/10.1182/blood-2022-159648
Published: 2022
Journal Articles

Cost-Effectiveness of Emicizumab for Prophylaxis in People with Severe Hemophilia A without Inhibitors

Marquita Decker-Palmer, Chia-Wei Lin, Michele Wilson, Cheryl McDade, Komal Bawa, Stacey Kowal, Arliene Ravelo, Elaine Yu, Richard H. Ko
Journal: Blood
Blood (2022) 140 (Supplement 1): 13041–13042.
https://doi.org/10.1182/blood-2022-162276
Published: 2022
Journal Articles

Real-World Assessment of Second Primary Malignancies in a Treated and Untreated Chronic Lymphocytic Leukemia Population in the United States

Sikander Ailawadhi, Arliene Ravelo, Carmen Ng, Bonny Shah, Rongrong Wang, Katherine Eakle, Juliana Biondo
Journal: Blood
Blood (2022) 140 (Supplement 1): 8040–8041.
https://doi.org/10.1182/blood-2022-158139
Published: 2022
Journal Articles

Real-World Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Receiving First-Line (1L) Therapy in the United States (US)

Anthony R. Mato, Arliene Ravelo, Tu My To, Robert Schuldt, Juliana M.L. Biondo
Journal: Blood
Blood (2021) 138 (Supplement 1): 4086.
https://doi.org/10.1182/blood-2021-148472
Published: 2021
Journal Articles

NHL Patients and Nurses in the US Prefer Subcutaneous Rituximab Injection Versus Intravenous Rituximab Infusion: A Real-World Study

Mitul D Gandhi, Sheila Shapouri, Arliene Ravelo, Lavanya Sudharshan, April Beeks, MPH, Keith L Dawson
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–9.
https://doi.org/10.1182/blood-2020-136543
Published: 2020
Journal Articles

Patient-Reported Disease Burden and Age: Results from a National Patient Advocacy Survey of Patients with Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Keith L. Dawson, DNP, MS, Mark A. Price, MA, MD, Peggy Ann Torney, MS, Victor Gonzalez, MA, MS, Maria Sae-Hau, PhD, Elisa S. Weiss, PhD, Brennan Mange, BA, Carol Mansfield, PhD, Eydith J Comenencia-Ortiz, PhD, Anthony S Masaquel, PhD MPH, Arliene Ravelo, MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 4778.
https://doi.org/10.1182/blood-2019-123644
Published: 2019
Journal Articles

Nurse Treatment Preferences Survey for Intravenous Rituximab Infusion Versus Subcutaneous Rituximab Injection: A Real-World Study

Mitul D. Gandhi, MD, Sheila Shapouri, PharmD, MS, Arliene Ravelo, MPH, Lavanya Sudharshan, MS, Jamyia Clark, MPH, Keith L. Dawson, DNP, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 5890.
https://doi.org/10.1182/blood-2019-123739
Published: 2019
Journal Articles

Cost-Effectiveness of a 12-Month Fixed Duration of Venetoclax in Combination with Obinutuzumab in First-Line Chronic Lymphocytic Leukemia in the United States

Matthew S. Davids, MD, Anuja Chatterjee, MSc, Arliene Ravelo, MPH, Sheila Shapouri, PharmD, MS, Beenish S Manzoor, PhD, Kavita Sail, PhD, Gijs Van de Wetering, PhD, Michael Hallek
Journal: Blood
Blood (2019) 134 (Supplement_1): 4741.
https://doi.org/10.1182/blood-2019-123706
Published: 2019
Journal Articles

What Are Patients' Preferences and Satisfaction Regarding Modes of Administration for the Treatment of Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-Cell Lymphoma (DLBCL), and Follicular Lymphoma (FL)?

Mark Price, MA, MD, Arliene Ravelo, MPH, Elisa Weiss, PhD, Peggy Ann Torney, MS, Victor Gonzalez, MHC-LP, Maria Sae-Hau, PhD, Carol Mansfield, PhD, Eydith Comenencia-Ortiz, PhD, Miko Cunanan, BS, Anthony Masaquel, PhD MPH, Keith L Dawson, DNP
Journal: Blood
Blood (2018) 132 (Supplement 1): 5897.
https://doi.org/10.1182/blood-2018-99-115327
Published: 2018
Journal Articles

Differences in Patients with Progressive Versus Non-Progressive AML, CLL, or NHL: Implications for Proposed Bundled Payment Strategies

Stacey Dacosta Byfield, PhD MPH, Nicole Engel-Nitz, PhD, Timothy Bancroft, PhD, Amy J Anderson, MS, Carolina Reyes, PhD, Arliene Ravelo, MPH, Sarika Ogale, PhD, May Chen, MD, Matthew J. Matasar, MD MS
Journal: Blood
Blood (2015) 126 (23): 4528.
https://doi.org/10.1182/blood.V126.23.4528.4528
Published: 2015